Antibiotic megacluster discovery opens new front against superbugs
▼ Summary
– Antibiotic resistance has been a threat since antibiotics were first used, as the drugs were originally borrowed from microbes engaged in a long evolutionary arms race.
– Over 80% of clinical antibiotics are based on microbial “natural products,” but new natural products have become harder to find, slowing the pipeline of new drugs.
– Existing antibiotics have been overused, leading to critical levels of resistance, with single mutations able to thwart many single-molecule drugs.
– A study in Nature led by Eric Brown reports the discovery of a “megacluster” of genes that codes for four molecules working together to disrupt a single metabolic pathway.
– This finding points to a potentially new antibiotic regimen and an entirely new strategy to regain an advantage in the microbial arms race.
The relentless rise of antibiotic resistance has cast a long shadow over modern medicine since the very dawn of the antimicrobial era. In the 20th century, these drugs transformed deadly bacterial infections into minor setbacks, a feat often hailed as a medical miracle. Yet, humanity didn’t truly invent antibiotics. We borrowed them from microbes, organisms locked in a silent, ancient war over survival. For centuries, microbial evolution has honed both potent toxins and cunning evasions as these tiny creatures battle for territory and resources. Today, more than 80 percent of clinical antibiotics are derived from these natural skirmishes, known in the lab as “natural products.”
For decades, scientists successfully mined these microbial molecules, tweaking them into new drugs to stay one step ahead of evolution’s countermoves. But that well has run dry. New natural products are increasingly scarce, and the pipeline for novel antibiotics has slowed to a near halt. Compounding the crisis, existing drugs have been overused, allowing resistance to reach dangerous levels. Most antibiotics consist of a single bioactive molecule, leaving them vulnerable to being neutralized by just one mutation. The situation is grim. However, a new study published this week in Nature offers a glimmer of hope, unveiling not just a potential new treatment but an entirely fresh strategy for regaining the upper hand in the microbial arms race.
The discovery centers on what researchers call a “megacluster” , a large block of genes that encodes four distinct molecules. Led by biomedical researcher Eric Brown at McMaster University in Ontario, Canada, the team found that these molecules appear to work together, targeting a single essential metabolic pathway with coordinated precision. This collaborative attack could make it far harder for bacteria to develop resistance, opening a new front in the fight against superbugs.
(Source: Ars Technica)
